Emerging therapies in traumatic brain injury

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/FMEB2013.14.50
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury?

  2013cited by this paper
• Erythropoietin neuroprotection with traumatic brain injury.

  2013cited by this paper
• Sulfonylurea receptor 1 in central nervous system injury: a focused review

  2012cited by this paper
• Neuroprotection and Estrogen Receptors

  2012cited by this paper
• A review of laboratory and clinical data supporting the safety and efficacy of cyclosporin A in traumatic brain injury.

  2011cited by this paper
• Erythropoietin Mediates Neurobehavioral Recovery and Neurovascular Remodeling Following Traumatic Brain Injury in Rats by Increasing Expression of Vascular Endothelial Growth Factor

  2011cited by this paper
• Erythropoietin as a Novel Brain and Kidney Protective Agent

  2011cited by this paper
• Multifunctional drugs for head injury

  2011cited by this paper
• Glibenclamide Reduces Hippocampal Injury and Preserves Rapid Spatial Learning in a Model of Traumatic Brain Injury

  2010cited by this paper
• Estradiol is a potent protective, restorative, and trophic factor after brain injury.

  2009cited by this paper
• Efficacy and safety of epoetin alfa in critically ill patients.

  2007cited by this paper
• Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats.

  2007cited by this paper
• Minocycline for Short‐Term Neuroprotection

  2006cited by this paper
• Neuroprotective Anti-Apoptosis Effect of Estrogens in Traumatic Brain Injury

  2005cited by this paper
• Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5α-reductase

  2004cited by this paper
• Severe traumatic brain injury.

  2001cited by this paper
• Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological Dysfunction

  2001cited by this paper
• Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives.

  1999cited by this paper
• A Case of Severe Cerebral Trauma in a Patient Under Chronic Treatment with Cyclosporine A

  1998cited by this paper
• Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures.

  1995cited by this paper
• Gender-specific impairment on Morris water maze task after entorhinal cortex lesion.

  1993cited by this paper
• Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells.

  1991cited by this paper
• The FASEB Journal express article 10.1096/fj.05-3907fje. Published online August 12, 2005. ©2005 FASEB

  year unknowncited by this paper

• Protective Effect of Diphenhydramine against Traumatic Brain Injury in Rats via Modulation of Oxidative Stress and Inflammation

  2019cites this paper
• Optical Coherence Tomography for Live Cochlea Visualization

  2018cites this paper
• Injury induced plasticity in primary neuronal culture and the mature brain

  2017cites this paper
• The effects of 7-nitroindazole on serum neuron-specific enolase and astroglia-derived protein (S100β) levels after traumatic brain injury

  2017cites this paper
• Fatty acid methyl esters as a potential therapy against cerebral ischemia

  2016influential citation
• Emerging Therapies in Traumatic Brain Injury

  2015cites this paper
• Emerging Therapies in Traumatic Brain Injury

  2015cites this paper